Compare EVO & IMSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVO | IMSR |
|---|---|---|
| Founded | 1993 | 2013 |
| Country | Germany | United States |
| Employees | 4553 | 74 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 994.5M | 901.5M |
| IPO Year | N/A | N/A |
| Metric | EVO | IMSR |
|---|---|---|
| Price | $2.88 | $6.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 29.8K | ★ 2.3M |
| Earning Date | 04-08-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.37 | N/A |
| Revenue Next Year | $10.05 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $5.33 |
| 52 Week High | $4.42 | $16.38 |
| Indicator | EVO | IMSR |
|---|---|---|
| Relative Strength Index (RSI) | 57.27 | 39.95 |
| Support Level | $2.88 | $5.82 |
| Resistance Level | $3.30 | $6.85 |
| Average True Range (ATR) | 0.06 | 0.62 |
| MACD | 0.03 | -0.12 |
| Stochastic Oscillator | 91.89 | 7.47 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Terrestrial Energy Inc is a technology company engaged in the development and commercialization of nuclear power plants. The company is focused on its proprietary Integral Molten Salt Reactor (IMSR) technology, a Generation IV reactor design intended to produce reliable, emission-free energy in the form of electricity and high-temperature heat for industrial applications. Its activities mainly involve advancing the design, licensing, and deployment of IMSR plants for commercial energy generation.